Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-up. - Nagler LK; Strunz PP; Labinsky H; Kroiß A; Gernert M; Schmalzing M (Frontiers in immunology, 2026)